Key Highlights

  • Hain Celestial (NASDAQ:HAIN): rose 9.62% to USD 0.1470, ahead of November 9, 2026 results.
  • Cognition Therapeutics (NASDAQ:CGTX): gained 8.37% to USD 0.769, ahead of a November 5, 2026 call.
  • PAVmed (NASDAQ:PAVM): climbed 9.95% to USD 2.10, ahead of a November 13, 2026 Business update.
  • J and Friends Holdings (NASDAQ:JF): dropped 25.52% to USD 0.7001, with no announcement identified.
  • Mercer International (NASDAQ:MERC): jumped 90.87% to USD 0.2405, after a planned Chapter 11 recapitalization.

Hain Celestial (NASDAQ:HAIN) (up USD 0.0129, 9.62%): Penny Shares Edge Higher Ahead of November 9 Results

Hain Celestial (NASDAQ:HAIN) was up 9.62% to USD 0.1470 in pre-market trading on November 3, 2026. No announcement tied to the move was identified. On November 2, 2026, the company said it will report fiscal 2027 first quarter results before the market opens on November 9, 2026, with a call at 8:00 AM ET.

Nasdaq granted a second compliance period through March 22, 2027 for the minimum bid price rule. Total Debt was USD 558 million and cash USD 58.1 million at June 30, 2026, and a lender extension of the December debt Maturity is still being pursued. Stocks below USD 1 carry heavy volatility, thin Liquidity and dilution risk.

Cognition Therapeutics (NASDAQ:CGTX) (up USD 0.0594, 8.37%): Penny Shares Inch Up Before the November 5 Call

Cognition Therapeutics (NASDAQ:CGTX) was up 8.37% to USD 0.769 in pre-market trading on November 3, 2026. The only identified release is a November 2, 2026 notice of a third quarter call at 8:30 a.m. ET on November 5, 2026, which contained no new data.

Its lead candidate, zervimesine, has an FDA aligned Phase 3 plan in dementia with Lewy bodies, per a June 24, 2026 filing. Cash was about USD 34.8 million at June 30, 2026, expected to last into the fourth quarter of 2027. A Phase 3 program will likely need more capital, so financing and share dilution are key risks.

PAVmed (NASDAQ:PAVM) (up USD 0.1900, 9.95%): Penny Shares Rise Ahead of a November 13 Update

PAVmed (NASDAQ:PAVM) was up 9.95% to USD 2.10 in pre-market trading on November 3, 2026. No announcement explaining the move was identified. The latest release, dated October 30, 2026, scheduled its third quarter business update call for November 13, 2026 at 8:30 AM ET and contained no financial results.

Cash was USD 3.8 million at June 30, 2026, against six-month operating expenses of USD 15.1 million. Calculated from those figures, cash covers roughly one quarter of spending at the first-half pace. The company depends on raising additional funding, so dilution is a risk.

J and Friends Holdings (NASDAQ:JF) (down USD 0.2399, 25.52%): Penny Shares Drop Without Fresh News

J and Friends Holdings (NASDAQ:JF) was down 25.52% to USD 0.7001 in pre-market trading on November 3, 2026, from a close of about USD 0.94. No company announcement was identified, and a data provider lists the next Earnings date as November 6, 2026, which the company had not confirmed in the material reviewed.

Full-year 2025 Revenue was about USD 1.6 million with a net loss of about USD 1.3 million, per market data. The company filed a USD 150 million shelf registration on April 27, 2026, which leaves open the possibility of future dilution.

Mercer International (NASDAQ:MERC) (up USD 0.1145, 90.87%): Penny Shares Recover Despite a Planned Chapter 11

Mercer International (NASDAQ:MERC) was up 90.87% to USD 0.2405 in pre-market trading on November 3, 2026. The implied prior close is about USD 0.126 (calculated). The company announced a Recapitalization on November 2, 2026 that would exchange about USD 1.1 billion of senior notes for Equity through a prepackaged Chapter 11 case.

Existing common stock would be cancelled, with holders receiving about 8.5% of the new common stock. The company expects Nasdaq to delist the stock, and third quarter results are scheduled after the market close on November 5, 2026.

Where Things Stand

Each of these five stocks has a scheduled event or a restructuring path ahead, yet only Mercer has a clear catalyst behind its move. Hain, Cognition and PAVmed rose without new data, while J and Friends fell with no identified cause. Track the November 5, 6, 9 and 13, 2026 event dates, any financing filings, Nasdaq notices and whether pre-market moves persist in regular trading.